These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2190450)

  • 1. Immune privilege and immune regulation in the eye.
    Niederkorn JY
    Adv Immunol; 1990; 48():191-226. PubMed ID: 2190450
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of inflammation on ocular immune privilege.
    Mo JS; Wang W; Kaplan HJ
    Chem Immunol Allergy; 2007; 92():155-165. PubMed ID: 17264491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts.
    Streilein JW; Yamada J; Dana MR; Ksander BR
    Transplant Proc; 1999 May; 31(3):1472-5. PubMed ID: 10330973
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune privilege in the anterior chamber of the eye.
    Niederkorn JY
    Crit Rev Immunol; 2002; 22(1):13-46. PubMed ID: 12186187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune privilege of the eye].
    Grisanti S
    Ophthalmologe; 1998 Feb; 95(2):124-35. PubMed ID: 9545793
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmunity in the eye and its regulation.
    Gery I; Streilein JW
    Curr Opin Immunol; 1994 Dec; 6(6):938-45. PubMed ID: 7710718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction: all for saving the visual axis.
    Ohashi Y
    Chem Immunol; 1999; 73():1-10. PubMed ID: 10590571
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.
    Taylor AW; Kaplan HJ
    Ocul Immunol Inflamm; 2010 Dec; 18(6):488-92. PubMed ID: 21091058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of ocular immune privilege in the year 2010: modifying the immune privilege of the eye.
    Hori J; Vega JL; Masli S
    Ocul Immunol Inflamm; 2010 Oct; 18(5):325-33. PubMed ID: 20849282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Privilege and Eye-Derived T-Regulatory Cells.
    Keino H; Horie S; Sugita S
    J Immunol Res; 2018; 2018():1679197. PubMed ID: 29888291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Termination of immune privilege in the anterior chamber of the eye when tumor-infiltrating lymphocytes acquire cytolytic function.
    Ksander BR; Mammolenti MM; Streilein JW
    Transplantation; 1991 Jul; 52(1):128-33. PubMed ID: 1907041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The eye and autoimmunity].
    Faure JP
    Arch Ophtalmol Rev Gen Ophtalmol; 1973 May; 33(5):441-8. PubMed ID: 4270425
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein.
    Hara Y; Caspi RR; Wiggert B; Chan CC; Wilbanks GA; Streilein JW
    J Immunol; 1992 Mar; 148(6):1685-92. PubMed ID: 1531843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.
    Skelsey ME; Mellon J; Niederkorn JY
    J Immunol; 2001 Apr; 166(7):4327-33. PubMed ID: 11254685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulators of immunological responses in the cornea and the anterior chamber of the eye.
    Jager MJ; Gregerson DS; Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():241-6. PubMed ID: 7556725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
    Gregory MS; Repp AC; Holhbaum AM; Saff RR; Marshak-Rothstein A; Ksander BR
    J Immunol; 2002 Sep; 169(5):2727-35. PubMed ID: 12193747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune privilege to MHC-disparate tumor grafts in the anterior chamber of the eye. I. Quantitative analysis of intraocular tumor growth and the corresponding delayed hypersensitivity response.
    Ksander BR; Streilein JW
    Transplantation; 1989 Apr; 47(4):661-7. PubMed ID: 2523103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulation of uveitis.
    Nussenblatt RB
    Int Ophthalmol; 1990 Jan; 14(1):13-8. PubMed ID: 2182561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.